Skip to content

Bard® Interglide™ Intermittent Catheter 430614Recalls & reported problems

C. R. Bard, Inc. · Interglide™ Female Coated Intermittent Catheter · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741077951), received between Jan 11, 2021 and Jan 11, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Improper Chemical Reaction” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Improper Chemical Reaction1

Patient problems

  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 11, 2021Improper Chemical Reaction; Improper Chemical Reaction

    IT WAS REPORTED THAT THE CATHETERS DID NOT HAVE ANY LUBRICATION ON THEM AND SO THE PATIENT HAD DIFFICULTY IN INSERTING. STATED THAT IT WAS VERY PAINFUL. IT WAS ALSO STATED THAT THE PATIENT USED WATER AS INSTRUCTED, BUT THAT DID NOT HELP. NO MEDICAL INTERVENTION WAS REPORTED.

    Patient problems: Pain

    MAUDE report 11147540 ↗

Other CATHETER, UROLOGICAL devices

All CATHETER, UROLOGICAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page